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High-fat diet in a mouse insulin-resistant model
induces widespread rewiring of the
phosphotyrosine signaling network
Antje Dittmann1,2,†, Norman J Kennedy3,†, Nina L Soltero1, Nader Morshed1,2, Miyeko D Mana1,4,
Ömer H Yilmaz1,4,5, Roger J Davis3,6,* & Forest M White1,2,7,**
Abstract
Obesity-associated type 2 diabetes and accompanying diseases have
developed into a leading human health risk across industrialized
and developing countries. The complex molecular underpinnings of
how lipid overload and lipid metabolites lead to the deregulation of
metabolic processes are incompletely understood. We assessed
hepatic post-translational alterations in response to treatment of
cells with saturated and unsaturated free fatty acids and the
consumption of a high-fat diet by mice. These data revealed wide-
spread tyrosine phosphorylation changes affecting a large number
of enzymes involved in metabolic processes as well as canonical
receptor-mediated signal transduction networks. Targeting two of
the most prominently affected molecular features in our data, SRC-
family kinase activity and elevated reactive oxygen species, signifi-
cantly abrogated the effects of saturated fat exposure in vitro and
high-fat diet in vivo. In summary, we present a comprehensive view
of diet-induced alterations of tyrosine signaling networks, including
proteins involved in fundamental metabolic pathways.
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Introduction
Metabolic syndrome, characterized by insulin resistance, dyslipi-
demia, hyperglycemia, elevated blood pressure, and hepatic steato-
sis, predisposes individuals to the development of a range of
disorders including type 2 diabetes, cardiovascular disease, nonalco-
holic fatty liver disease, and cancer (Almind et al, 2005; Biddinger &
Kahn, 2006; Font-Burgada et al, 2016). A combination of environ-
mental and genetic factors such as overnutrition, increased lipolytic
activity, and adipocyte hypertrophy has been found to be important
for the development of the syndrome, and insulin resistance appears
to be central to the establishment of disease (Dahlman et al, 2017;
Gustafson et al, 2015). Insulin resistance describes a range of molec-
ular phenotypes in which physiological regulatory functions of
insulin are suppressed or altered. In peripheral tissues such as skele-
tal muscle and adipose tissue, insulin regulates glucose uptake,
whereas in the liver, it suppresses gluconeogenesis. In addition,
insulin stimulates postprandial lipogenesis and the synthesis of
glycogen and protein, but inhibits lipolysis, glycogenolysis, and
protein catabolism (Saltiel & Kahn, 2001). The liver plays a central
role in many of these processes, and hepatic insulin resistance is
thought to contribute to glycemic dysregulation whereby insulin
fails to suppress hepatic gluconeogenesis but still activates lipogene-
sis (Brown & Goldstein, 2008).
The underlying molecular mechanisms of hepatic insulin resis-
tance are still incompletely defined, but impaired control of gluco-
neogenesis is commonly linked to attenuated insulin signaling
through Akt, a canonical downstream serine/threonine kinase that
modulates and controls liver metabolism through several signaling
cascades of kinase-mediated protein phosphorylation (Leavens &
Birnbaum, 2011; Haeusler et al, 2014). However, studies of the
paradoxical effect of insulin on concomitant lipogenesis and gluco-
neogenesis have challenged this view and have led to the proposal
that a non-autonomous pathway of hepatic gluconeogenesis regula-
tion is mediated by adipocyte lipolysis (Lu et al, 2012; Perry et al,
2015; Titchenell et al, 2015, 2016). Evidently, glucose production in
the liver underlies insulin-independent regulatory mechanisms that
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are controlled by excess free fatty acids (FFAs) and a subsequent
increase in hepatic acetyl CoA-mediated pyruvate carboxylase activ-
ity (Ashman et al, 1972; Perry et al, 2015). In addition, obesity and
insulin resistance have been associated with elevated levels of reac-
tive oxygen species (ROS) due to enhanced fatty acid utilization in
mitochondria, increased ER stress, and increased expression and
activation of NADPH oxidases (NOXs; Vincent & Taylor, 2005;
Houstis et al, 2006; Nakamura et al, 2009; Lefort et al, 2010; Jiang
et al, 2011; Rindler et al, 2013; Furukawa et al, 2017). The ensuing
oxidative stress and shift in the redox environment result in macro-
molecule damage but also constitute an additional signaling layer
capable of modifying regulatory nodes in insulin and other signaling
pathways. Under normal physiological conditions, ROS, especially
hydrogen peroxide (H2O2), act as second messengers that are intri-
cately tied into the transient regulation of ligand-induced tyrosine
phosphorylation signaling (Meng et al, 2004; Rhee, 2006; Tonks,
2006; Karisch & Neel, 2013). In contrast, in obesity and insulin resis-
tance, excess ROS have been shown to modify mitogen-activated
protein kinase (JNK, p38), SRC, and IKKb signaling, either indirectly
through oxidation of phosphatases and other endogenous inhibitors,
or through direct oxidation of the kinase (Adler et al, 1999; Liu
et al, 2000; Storz & Toker, 2003; Kamata et al, 2005; Kemble & Sun,
2009; Tiganis, 2011; Truong & Carroll, 2013). Consequently,
phosphotyrosine (pTyr) phosphatases (PTPs) have been found to
differentially undergo reversible oxidation of a conserved catalytic
cysteine under long-term (12 and 24 weeks) high-fat diet conditions
in mice, leading to their inactivation and a rewiring of the
insulin-STAT5 network without showing global effects on phospho-
tyrosine signaling (Gurzov et al, 2014). Likewise, blocking SRC
activity with short-term treatment of the dual ABL/SRC tyrosine
kinase inhibitor dasatinib led to improved glucose tolerance, and
hepatic JNK1/2 ablation improved insulin sensitivity in models of
diet-induced obesity (DIO; Holzer et al, 2011; Vernia et al, 2014,
2016).
Molecular and cellular models of diet-induced insulin resistance
are being explored to understand the complex tissue-specific events
during overnutrition that drive the progression of insulin resistance
and diabetes. To that end, system-level approaches have helped to
elucidate the wide-ranging alterations in protein, RNA, and
metabolite levels associated with obesity, and may help open up
novel avenues for therapeutic intervention (Sabido´ et al, 2013;
Soltis et al, 2017; Krahmer et al, 2018; Li et al, 2018). However, to
date, only limited data on the fatty acid-induced changes of basal
hepatic phosphotyrosine networks have been collected, oftentimes
relying on antibody detection of selected phosphorylation sites.
Combined with the low abundance of many tyrosine phosphory-
lated proteins and substoichiometric phosphorylation levels, such
targeted approaches leave an important and dynamic signaling
layer regulating many biological processes underexplored. To
address this knowledge gap in a more comprehensive and unbi-
ased manner, we monitored diet-induced changes in hepatic phos-
photyrosine signaling in vitro and in vivo using multiplexed
quantitative mass spectrometry. We investigated the role of FFAs
in rewiring the tyrosine network of the rat hepatoma cell line
H4IIE treated with the saturated fatty acid palmitate or monounsat-
urated oleate. These studies revealed a significant increase in tyro-
sine phosphorylation when treated with palmitate but not oleate,
accompanied by features of insulin resistance. Tyrosine network
analysis of livers from a DIO model displayed very similar trends
with a substantial number of phosphotyrosine sites (111 of 352)
being altered in high-fat diet (HFD) conditions, while diet effects
on hepatic protein content were limited to approximately 14% of
all quantified proteins. Interestingly, the majority of affected tyrosi-
nes reside in metabolic enzymes involved in glycolysis, the tricar-
boxylic acid cycle (TCA), glycogen synthesis, and amino acid
metabolism, indicating a widespread dysregulation of crucial
hepatic metabolic processes. Quantification of diet-induced pTyr in
liver-specific insulin receptor knockout animals (LIRKO) demon-
strated that only a subset of these phosphorylation changes could
be attributed to hyperinsulinemia and persistent insulin receptor
signaling. Moreover, PA-altered phosphorylation of a subset of
tyrosines could be reversed using the antioxidants N-acetylcysteine
(NAC) and butylated hydroxyanisole (BHA) in vitro, prompting us
to investigate the impact of BHA on the pTyr network and monitor
phenotypic effects in mice on HFD. Consistent with the presumed
effect of ROS on tyrosine kinases and phosphatases, BHA treatment
led to a remarkable reversal of HFD-induced changes in the tyro-
sine network (160 of 377 sites) and restored glucose and insulin
response. Overall, the data reveal substantial and previously
unknown responses to overnutrition and saturated FFA on poten-
tial regulatory sites of critical metabolic enzymes. These changes
may explain the dysregulating effects of long-term caloric excess
on hallmarks of diabetes such as persistently increased gluconeoge-
nesis, and provide additional proof for insulin-independent effects
of systemically elevated FFAs.
Results
Palmitate induces insulin resistance in vitro and increases
tyrosine phosphorylation signaling
The role of FFAs in transcriptional control has been demonstrated
(Papackova & Cahova, 2015), but, to date, information on the
system-level effects of FFAs on signal transduction networks is lack-
ing. Therefore, we sought to elucidate the effects of acutely elevated
FFAs on hepatic signaling networks with the goal of identifying new
network nodes whose activities are modified by FFAs. We used a
well-established cell-based model to analyze the effects of BSA-
conjugated saturated (PA—palmitic acid) and BSA-conjugated
monounsaturated (OA—oleic acid) FFAs, as well as unconjugated
BSA as a control, on Akt phosphorylation, ROS, glucose 6-phospha-
tase (G6Pase) expression, and pTyr levels. Consistent with PA
promoting an insulin resistance-like phenotype (Stabile et al, 1998;
Xu et al, 2007; Nakamura et al, 2009; Egnatchik et al, 2014; Gurzov
et al, 2014), treating the rat hepatoma cell line H4IIE with PA for
24 h led to an attenuated pAkt (S473) response to insulin (Figs 1A
and EV1A), and increased ROS (Fig 1B) and G6Pase mRNA, relative
to OA, without impairing the expected insulin-induced increase of
INSR/IGF1R phosphorylation and reduction of G6Pase expression
(Fig 1C). To determine the effects of PA and OA on pTyr signaling
in these cells, pTyr-containing peptides were labeled with isobaric
mass tags (TMT; Thompson et al, 2003) for multiplexing, enriched
by a two-step protocol to reduce sample complexity, and analyzed
by quantitative LC-MS/MS (Fig 1D). This analysis led to the identifi-
cation and quantification of hundreds of pTyr-containing peptides
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(Dataset EV1). Hierarchical clustering of pTyr levels relative to the
BSA control revealed that the phenotypic responses to PA were
accompanied by a dose- and time-dependent marked increase in
tyrosine phosphorylation (Fig 1E). Pathway analyses of significantly
changed pTyr sites showed enrichment of receptor tyrosine kinase
(RTK)-linked signal transduction processes coupled to MAPK
cascades (Fig 1F). In particular, phosphorylation sites on the activa-
tion loops of ERK1/2 (ERK2-T183, Y185, ERK1-Y205) and JNK1/2
(JNK1/2-T183, Y185) were elevated upon PA treatment, which was
verified by Western blotting (Fig EV1B). Furthermore, these sites
co-clustered with similarly increased pTyr sites of the RTK MET
(Y1001), and RTK-linked downstream and adaptor proteins (NCK1-
Y105, PI3K P85A-Y467 and Y580, PI3K P55G-Y199, PTPN11-Y62
and Y584, CRK-Y136, CRKL-Y132, FER-Y402 and Y715, SHC1-Y349,
Y423, Dataset EV1), contributing to the enrichment of MAPK- and
RTK-associated pathways in the pool of signaling nodes that were
upregulated by PA but not OA. In addition, we found multiple sites
on SRC, and other SFK family members that were markedly
increased by PA treatment at various concentrations (Dataset EV1),
including an upregulated activation loop tyrosine common to SRC,
LCK, FYN, HCK, and YES1. Upregulation of the phosphorylation of
the activation loop tyrosine was verified manually for each experi-
ment (Fig EV1C). This analysis also showed that protein levels of at
least two of the SFK members were not affected by the duration of
treatment or FFA concentration (Fig EV1D). These data suggest that
key signaling network nodes, associated with each other through
direct and indirect interactions, biological functions, and/or local-
ization patterns (Sorkin & von Zastrow, 2009; Holzer et al, 2011),
are strongly regulated by saturated FFA-induced phosphorylation
changes. Many of these phosphorylation sites belong to a group of
proteins linked to SFK activity, either as direct substrates or interac-
tion partners, or through changes in their phosphorylation status as
a response to SFK inhibition (Luo et al, 2008; Rubbi et al, 2011;
Ferrando et al, 2012; Giansanti et al, 2014). Accordingly, ranking
proteins based on their maximal normalized fold-changes revealed
significant enrichment of SFK substrates after PA treatment, but not
OA treatment, in a phospho-set enrichment analysis (PSEA) of
known SFK substrates such as MCM7, FER, and SHC1 (Fig 1G,
Dataset EV1; Subramanian et al, 2005; preprint: Sergushichev,
2016).
High-fat diet induces widespread rewiring of the hepatic
phosphotyrosine network
To determine whether the in vivo effects of high-fat diet (HFD) on
mouse livers would mimic the in vitro effects of saturated fatty acids
on hepatocytes, we used an established DIO model in C57BL/6J
mice that has been shown to mirror hepatic dysfunction and signal
transduction changes observed in patients (Collins et al, 2004; Soltis
et al, 2017). Using a staggered HFD start to obtain an age-matched
end-point, male mice were fed a normal chow diet (NC) or HFD for
6 or 16 weeks before euthanasia, liver resection, and analysis of the
hepatic proteome and pTyr changes by LC-MS/MS (Fig EV2A). Mice
fed a long-term HFD showed significantly increased obesity and
insulin resistance-related phenotypes, including elevated body
weight, fat mass, and blood glucose, and exhibited impaired toler-
ance to both glucose and insulin, relative to age-matched NC-fed
mice (Fig EV2B and C).
We examined diet-associated differences in pTyr levels by
comparing livers of HFD-fed mice (6 and 16 weeks, data set 1) to
livers of age-matched NC-fed mice to capture different temporal
windows of insulin resistance progression. Data from different MS
runs were aligned by including the same normalization sample in
each analysis to allow for inter-run comparisons through normaliza-
tion relative to that sample. These analyses revealed significantly
increased pTyr levels in the liver of HFD-fed mice for a considerable
number of sites (111 of 352) after 16 weeks (Fig 2A, Dataset EV2),
but not after 6 weeks. However, many of the significantly increased
sites at week 16 displayed slightly elevated ratios already after
6 weeks, suggesting that HFD leads to a dysregulation of pTyr levels
on cellular signaling nodes that accumulate over time. This effect is
largely unidirectional, as the vast majority of significantly altered
pTyr peptides exhibit increased levels relative to normal chow in
both HFD conditions (Fig 2B).
To validate the general trends and translatability of the in vivo
effects of HFD on liver signaling networks, we repeated the analysis
in an independent cohort of female C57BL/6J mice fed a HFD for 12
and 30 weeks and age-matched NC control animals (data set 2).
The mice were fed ad libitum prior to euthanasia and liver resec-
tion. In agreement with the first data set (Fig 2A and B), we
observed a general trend toward significantly elevated pTyr levels
compared with NC-fed mice on approximately 20% of all identified
sites, predominantly in animals that were fed a 12-week HFD
(Figs 2C and EV2D, Dataset EV3). The 266 peptides common in
both analyses included 76 out of the 111 pTyr sites that were signifi-
cantly changed by diet in data set 1. The majority of them corre-
spond to metabolic enzymes and RTK-associated signaling nodes,
and exhibited comparable responses to HFD in both cohorts
(Fig 2D). Taken together, we found that, within the canonical
insulin signaling network, HFD resulted in increased pTyr relative
to NC on the Insulin receptor (INSR) and associated adaptor
proteins insulin receptor substrate 2 (IRS2), GAB1 and SHC1, as
well as the PI3K p85 regulatory subunit and PLCG1. Downstream of
these nodes, feeding a HFD resulted in increased p38a phosphoryla-
tion on the activation loop, whereas the other MAPKs were not
reproducibly detected or not significantly affected by diet. Although
phosphorylation of the canonical INSR pathway was increased, the
majority of upregulated pTyr sites were found in metabolic enzymes
that are involved in glycolysis/gluconeogenesis/glycogenesis
(F16P1, PYC, ALDOB, PGK1, Enolase, LDHA, PGM1, GSK3a/ß),
urea cycle (ASSY, ARGI1), TCA cycle (FUMH, IDHC, DHE3), amino
acid catabolism (FAAA, PH4H, HPPD, MAA), the fatty acid cycle
(ECHA, THIM), and the retinol (AL1A1, AK1A1) and sarcosine
(M2GD, BHMT1, SAHH) pathways, suggesting an HFD-induced
rewiring of enzyme activities associated with important metabolic
functions, or effects on protein stability or localization of these
proteins. Interestingly, the response to diet for tyrosine phosphory-
lation on EGFR and the non-receptor tyrosine kinases JAK2, FAK1,
and LYN as well as the common SFK activation loop site showed
opposite patterns between the two data sets (down in data set 1, up
in data set 2). While EGFR pTyr levels in 12- and 30-week HFD
(data set 2) track with protein levels, which were significantly
increased (Fig 3A), FAK1, JAK2, and SFK expression did not change
under HFD12 or HFD30 in these mice.
In order to assess whether pTyr level changes in data set 1 were
due to altered signaling activity or protein expression, we quantified
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protein levels in NC-fed and HFD-fed mice (16 weeks) by LC-MS/
MS. Although HFD consumption led to a significant change of many
of the identified pTyr sites, only ~14% of proteins (642 of 4,459
proteins, Fig 3B, Dataset EV4) displayed divergent expression
patterns under HFD conditions relative to NC, with more proteins
being downregulated in HFD16 vs. NC (392 vs. 250). Analysis of
enriched GO terms in the group of significantly upregulated proteins
revealed a prevalence of lipid metabolic pathways, while the group
of downregulated proteins was enriched in oxidation–reduction
processes (Fig 3C). Proteins associated with lipid metabolism, trans-
port, and ß-oxidation included apolipoproteins, fatty acid binding
proteins, and mitochondrial proteins [e.g., acetyl-CoA acetyltrans-
ferase ACAT1 (THIL), acyl-CoA dehydrogenase (ACADM); Fig 3D,
left panel], whereas a large number (> 20) of cytochrome P450
A
C
F G
D
B E
Figure 1. Palmitate induces insulin resistance phenotype in vitro and profoundly perturbs signal transduction pathways.
A Akt phosphorylation (S473) after insulin stimulation in the presence of FFAs. Cells were treated with BSA-conjugated palmitic acid (PA), oleic acid (OA), or BSA alone
(0.1 mmol/l final FFA concentration) for 24 h before being stimulated with 100 nmol/l insulin for 1–15 min. Proteins were extracted and immunoblotted with
anti-pAkt-S473, anti-pERK-T202/Y204, and anti-pINSR-Y1189/90.
B Reactive oxygen (ROS) levels after treatment with 0.1 mmol/l FFA. Cells were grown in the presence of FFA or BSA alone for indicated times, and ROS levels were
measured and expressed as ratios relative to time-matched BSA (mean  SEM; n ≥ 3; *P-value < 0.05; **P-value < 0.01; ***P-value < 0.001, n.s., not significant
using unpaired Student’s t-test, two-sided).
C Expression levels of glucose-6-phosphatase (G6Pase) after incubating cells with 0.1 mmol/l FFA or BSA alone. Three hours before the end of each time point, cells
were stimulated with 100 nmol/l insulin or left unstimulated before RNA extraction. RNA levels are expressed as ratios of treatment and time-matched unstimulated
BSA control (mean  SEM; n ≥ 3; *P-value < 0.05; **P-value < 0.01; ***P-value < 0.001; n.s., not significant using unpaired Student’s t-test, two-sided).
D Schematic workflow to study the effects of acute levels of FFAs on signal transduction pathways in hepatic cells. Rat H4IIE cells were incubated with increasing
concentrations of PA, OA, or BSA alone for different time points. Phosphotyrosine peptides were prepared as described and analyzed by LC-MS/MS.
E Unsupervised hierarchical clustering of pTyr peptide levels from cells treated with OA or PA (n ≥ 2). Abundances are expressed as ratios (log2) relative to time-
matched BSA controls.
F Enrichment analysis of biological processes (GO-BP, DAVID) using proteins with peptides that are significantly different in PA vs. OA in any condition (P-value ≤ 0.05).
Terms were filtered using BH-adjusted P-values (P-value ≤ 0.03).
G PSEA to test for enrichment of SFK substrates (PhosphoSite Plus) using rank-ordered maximal normalized fold-changes for each protein.
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family members was in the pool of proteins downregulated in HFD
(Fig 3D, right panel). We assessed the general reliability of our data
by benchmarking it against previously published liver proteomes
(Ghose et al, 2011; Benard et al, 2016; Liu et al, 2017; Soltis et al,
2017; Krahmer et al, 2018). Enrichment of the top GO terms in the
up- and downregulated sets are consistent with these reports, and,
despite stringent protein filters which reduced the number of quanti-
fied proteins from ~5,200 to ~4,400, our protein numbers are well
within the range of those studies (950–6,000).
Overall, diet-induced changes in protein abundance only poorly
tracked with diet-induced changes in pTyr levels (R2 = 0.25, Fig 3E)
and therefore could not fully explain the impact of diet on tyrosine
signaling. Some of the most notable exceptions include fructose-1,6-
bisphosphatase 1 (F16P1), FAK2, and the aforementioned acetyl-
CoA acetyltransferase (THIL), which are among the 26 proteins
whose expression and tyrosine phosphorylation trend concordantly
in HFD16 (Fig EV3A and B), including proteins where both
measures track at different magnitudes (e.g., EGFR, CYP7B, CAH3).
Divergent patterns of expression and phosphorylation were
observed for INSR and EF1A1, where phosphorylation was signifi-
cantly up in spite of significantly decreased expression levels in
HFD16 vs. NC. Taken together, these data indicate that
A
B
C
D
Figure 2. HFD-induced rewiring of phosphotyrosine signaling in vivo affects metabolic enzymes and RTK-associated proteins.
A Analysis of basal phosphotyrosine levels in aged-matched NC and HFD male mice by unsupervised hierarchical clustering of peptide abundances relative to the
normalization sample (log2, data set 1). Only peptides quantified in at least two animals per condition were used. Differential regulation in any pairwise comparison was
determined using a combination of moderated and standard t-test, and rank products. P-values were corrected for multiple comparisons using Benjamini-Hochberg.
B Summary of the number of differentially regulated phosphotyrosine peptides in all pairwise comparisons plotted on a log10 scale (data set 1, male mice).
C Summary of the number of differentially regulated phosphotyrosine peptides in pairwise comparisons between NC and HFD samples from study 2 plotted on a log10
scale. Abundances of peptides from female C57BL/6J mice (n = 2 each) on 12- or 30-week HFDs and matched NC animals were analyzed as described in data set 1
and significance was assessed as described above.
D Abundance of peptides in HFD relative to NC (log2) that were significantly changed in (A) (n = 2–4, male mice) and their HFD levels relative to age-matched NC control in
data set 2 (female mice). Number after protein name indicates amino acid position of phosphorylated tyrosine in mouse protein, while number at end corresponds to
peptide form (e.g., methionine oxidation, missed cleavage). White squares indicate that peptide was not identified in LC-MS/MS analysis. SFKs—SRC, LCK, YES, FYN, HCK.
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overnutrition leads to a rewiring of enzymatic activity associated
with metabolic signaling cascades that is only in part dependent on
the impact of diet on protein content, whereas the activity of canoni-
cal RTK-signaling nodes such as EGFR, JAK2, and SFK was found to
be linked to protein level changes in one or both studies.
Hyperinsulinemia only partially explains increased tyrosine
phosphorylation caused by HFD consumption
The widespread effects of HFD consumption on basal tyrosine phos-
phorylation, together with reduced tolerance to glucose and insulin,
prompted an investigation of the pTyr-signaling response to insulin
stimulation with the goal of defining the molecular mechanisms
underlying insulin resistance in this model. Mice fed a NC diet or
HFD (6 and 16 weeks) were fasted overnight and treated with
insulin for 15, 30, or 60 min prior to euthanasia, liver resection,
and subsequent signaling network analysis (Fig 4A). Consistent
with literature reports, HFD-fed mice (6 or 16 weeks) were insulin-
resistant, with significantly decreased pAkt levels following insulin
stimulation relative to NC diet-fed mice (Fig 4B). At the pTyr
network level, a similar response to insulin stimulation was
detected across diet conditions for INSR (activation loop tyrosines),
and on sites of the immediate downstream node IRS1 with respect
to magnitude and time response, suggesting peak activation of these
A C
B
D
E
Figure 3. HDF regulates the expression of a subset of hepatic proteins.
A Immunoblot of total EGFR, SFKs, FAK1, and JAK2 levels in individual liver extracts in data set 2 (female mice). Lane labels correspond to duration of HFD (30 or
12 weeks) and number of replicate.
B Volcano plot of average expression ratios (log2 scale) of proteins in HDF16 relative to NC mice (male, n = 2–3, data set 1) and P-values as assed by Student’s t-test.
Two-dimensional kernel density of points was estimated per square in a grid of 100 × 100.
C Enrichment of gene ontology biological processes (DAVID GO-BP) in proteins whose expression is significantly changed by HFD16 relative to NC (P-value < 0.05,
Fig 3B). All identified liver proteins were used as background.
D Ratios (log2) of selected proteins in livers of NC and HFD16 mice relative to normalization sample. Proteins associated with significantly enriched GO-BP terms
“cofactor metabolic process” and “oxidation-reduction process” in up- and downregulated group, respectively (Fig 3B), were evaluated
(median + quartile3 + 1.5*IQR/median – quartile1-1.5*IQR; n ≥ 2; *P-value < 0.05; **P-value < 0.01; ***P-value < 0.001 using unpaired Student’s t-test, two-sided).
E Scatter plot of HFD16 protein and corresponding pTyr abundances relative to NC in study 1 (log2). Data were fitted with a linear regression model. Indicated proteins
display significant change in protein expression and pTyr.
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proteins after 15 min of insulin treatment (Fig 4C). Despite this
similarity in receptor activation, HFD resulted in altered insulin
response signaling throughout most of the rest of the network,
including on receptor proximal adaptor proteins such as IRS2,
where almost all sites were dysregulated in terms of either initial
response, e.g., Y734, or temporal response, e.g., Y970 (Fig 4D,
Dataset EV2). Already decreased EGFR phosphorylation levels fell
further after 60 min of insulin stimulation in 16 weeks of HFD-fed
mice, suggesting a crosstalk between insulin signaling and the
EGFR network. Further down in the network, phosphorylation of
adaptor proteins including PI3K P85A (Y580, Y467), NCK1 (Y105),
NCK2 (Y110), SHC1 (Y423), CRKL (Y132), GAB1 (Y407), and PLCG
(Y771) was increased by 6 or 16 weeks of HFD or both, and either
stayed elevated or paradoxically decreased (PLCG Y771, 6 weeks of
HFD) following stimulation (Dataset EV2). Similarly, HFD-downre-
gulated LYN sites responded positively to insulin only after
16 weeks of HFD but decreased in response to stimulation in NC-
fed mice and 6 weeks of HFD-fed mice, converging to similar levels
in all three diets after 60 min. The majority of metabolic network
pTyr sites that were significantly increased by HFD were only
responsive to insulin in the NC-fed mice; in the 6 weeks of HFD-fed
mice, the response to insulin was generally higher in magnitude
compared to their NC counterparts, but these sites completely failed
to respond to stimulation in 16 weeks of HFD-fed mice (Fig 4E). In
general, the basal 16 weeks of HFD-fed mice phosphorylation levels
for those enzymes were markedly higher than their insulin-induced
levels in NC, indicating not just a lack of response to insulin, but
rather a diet-induced deregulation and potential activation of these
pathways.
To test whether hyperinsulinemia and continuously elevated
receptor signaling acted as a major driver of increased basal tyro-
sine phosphorylation levels, we used a liver insulin receptor
knockout model (LIRKO, Fig 5A; Michael et al, 2000). The animals
were healthy and phenocopied control mice performance on a
glucose tolerance test (GTT) and weight gain (Fig EV4A and B).
Male Alb-cre InsrLoxP/LoxP (LIRKO) and InsrLoxP/LoxP (Control) mice
were fed a HFD (16 weeks) before analyzing hepatic pTyr levels
(Fig 5B). The vast majority of sites (131 out of 157, Fig 5C,
Dataset EV5) were similarly affected by HFD in the livers of LIRKO
and control mice, indicating that most diet-induced alterations to
pTyr signaling are independent of hepatic INSR signaling.
However, liver-specific Insr knockout in combination with HFD
did lead to decreased phosphorylation on known (IRS2-Y814,
Y671, CEAM1/2-Y514/515), and potential new (AL1A1/7-Y484,
ACBP-Y29, CAH3-Y74, DHE3-Y193, CLH1-Y899, Y1096) direct and
indirect INSR targets and adaptor proteins, of which only a small
group was increased by HFD relative to NC (Fig 5D). Loss of the
insulin receptor also resulted in significant upregulation in pTyr
levels for some sites after 16 weeks of HFD, including EGFR-
Y1197, F16P1-Y216, PYC-Y118, and Stat3-Y705. For a subset of
these proteins, we analyzed mRNA levels by qPCR and found that,
with the exception of PYC (no expression change) and IRS2 (in-
creased RNA level, decreased pTyr), significant changes in mRNA
levels (Fig 5E) track with observed changes in pTyr levels.
Together with decreased EGFR phosphorylation levels after 60 min
of insulin treatment, these data suggest a connection between
INSR signaling and the regulation of EGFR expression/activity,
specifically in male mice.
Inhibiting SFK activity and decreasing ROS burden reduces
phosphotyrosine levels in vitro
Since treatment with saturated, but not monounsaturated FFA
causes an insulin resistance phenotype with a concomitant increase
in tyrosine signaling in vitro similar to HFD-induced phosphoryla-
tion changes detected in vivo, we next wanted to define and test
points of intervention leading to a restoration of physiological
hepatic function. Increased oxidative stress is tightly associated with
obesity and insulin resistance caused by nutrient overload,
inflammation, and ER stress (Houstis et al, 2006; Tiganis, 2011). In
addition, altered redox environments have also been shown to
directly affect SFK activities (Kemble & Sun, 2009; Paulsen &
Carroll, 2013). To determine whether increased ROS, and conse-
quently decreased PTP activities or SFK activation may be responsi-
ble for the altered signaling in response to FFA, we treated H4IIE
hepatoma cells with OA or PA in the presence of the antioxidants N-
acetyl-L-cysteine (NAC) and butylated hydroxyanisole (BHA) or the
complex I inhibitor rotenone, and then subjected these samples to
pTyr analysis by LC-MS/MS. Principal component analysis of the
pTyr response to treatment showed that treating cells with NAC or
BHA in the presence of PA moved these treatment groups closer to
conditions that include OA when projected on the second coordinate
axis as compared to PA alone (Fig 6A). This indicates that counter-
ing increased ROS levels aids in restoring some of the signaling
networks that were altered by saturated FFA. Indeed, the thiol-
containing NAC was similarly effective in reducing PA-induced tyro-
sine phosphorylation as the non-thiol BHA, but also showed small
differences. Rotenone treatment, on the other hand, was very simi-
lar to palmitate treatment alone and did not modulate PA-induced
phosphorylation at all (Fig EV5A, Dataset EV6). Focusing on the
former two treatments, we were able to identify more than 30 tyro-
sine sites whose phosphorylation was significantly decreased by the
combination of PA +BHA or PA +NAC. This set includes well-char-
acterized SFK substrates and associated kinases (e.g., tensin, talin,
calmodulin, paxillin, ABL1, FER, SHC1, PTPN11, cortactin), in addi-
tion to aspects of canonical RTK signaling (e.g., PI3K P85A, PI3K
P85B, SHP-2), and MAPKs, including p38, and JNK2 (Dataset EV6).
In contrast to the selective antioxidant effects, treating cells with the
SRC-family/ABL kinase inhibitor dasatinib (Agostino et al, 2010)
reversed PA-induced tyrosine phosphorylation in a concentration-
dependent manner on approximately 58% of identified sites (139
out of 284, Fig EV5B, Dataset EV6). In general, the response to the
inhibitor was similar in OA and PA with phosphorylation levels that
were reduced to below the BSA reference in the presence of either
FFA. With the exception of p38a-Y182, dasatinib failed to suppress
PA-induced MAPK phosphorylation, suggesting sustained JNK and
ERK activities (top cluster). Sites most strongly responding to SFK
inhibition comprised several SFK sites and known substrates (e.g.,
paxillin, WASL, bottom clusters), whereas other known SFK
substrates were aggregated into the middle cluster, which is charac-
terized by phosphorylation levels that were reduced to levels seen
in BSA in response to dasatinib. Some representatives of this cluster
are enzymes involved in cell motility/cytoskeleton as well as glycol-
ysis/gluconeogenesis, including phosphoglycerate kinase (PGK1),
lactate dehydrogenase A (LDHA), and enolase (ENO), suggesting a
link between changes in the SFK-related signaling machinery and
metabolic reprogramming in the liver. Encouraged by the mitigating
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effects on signaling, we investigated downstream responses to treat-
ing cells with NAC or dasatinib in the presence of FFA and moni-
tored G6Pase expression and pAkt responses to insulin. Only NAC
administered at high concentrations was able to reverse palmitate-
induced increase in G6Pase expression (Fig 6B), but no mitigating
effects of NAC, BHA, or dasatinib on the suppressed pAkt response
were detected (Figs 6C and EV5C–F). Similarly, dasatinib failed to
reduce ROS levels that were increased by PA (Fig EV5G). Interest-
ingly, treating cells with high concentrations of NAC led to a
decrease in insulin-induced INSR phosphorylation across all three
FFA/BSA treatment conditions (Fig 6C, top panel). This appears to
be in agreement with reports of the localized, transient, and rever-
sible insulin sensitivity-promoting activities of ROS through the
inactivation of negative regulators of growth factor receptor signal
transduction such as PTP1B (Loh et al, 2009; Tiganis, 2011).
Targeting ROS in vivo reverses HFD-induced increase of tyrosine
phosphorylation on some but not all sites
Due to the selective downregulating effects of BHA and NAC in the
cell-based model, we were curious to see whether antioxidant prop-
erties would be effective in vivo, with the ultimate goal of protecting
from diet-induced upregulation of tyrosine signaling. We used the
same 16-week HFD model as described above, with one group of
animals receiving BHA supplemented in the HFD and fed ad libitum,
whereas the control group was fed the same HFD without BHA. LC-
MS-/MS-based pTyr analysis was performed on the BHA-treated and
control livers to establish the network-wide effects of BHA supple-
mentation. Intriguingly, BHA supplementation led to a significant
decrease in phosphorylation on a substantial number of pTyr sites
(160 of 377, Fig 6D, Dataset EV7) relative to HFD controls, with
another 36 sites that were significantly increased. In agreement with
cell-based data, we saw a strong decrease of INSR phosphorylation
and a concomitant decrease of CEAM1/2-Y515/514, a protein
directly involved in INSR internalization (Poy et al, 2002) and
linked to INSR activity as shown in the LIRKO mice (Fig 5C and D).
The most strongly upregulated tyrosine sites belong to the super
family of glutathione S-transferases (GSTPs, GSTMs), which play a
major role in the detoxification of electrophilic chemicals. Compar-
ing across treatment conditions and datasets, 46 pTyr sites were
significantly altered by HFD relative to NC and were significantly
affected by BHA treatment relative to the HFD control (Fig EV6A).
Although almost all (39/46) of these sites were upregulated in
HFD16 relative to NC and downregulated in the presence of BHA,
there were seven tyrosine sites whose phosphorylation levels were
even further increased by BHA supplementation. These data suggest
that BHA does not fully revert the impact of HFD and HFD-induced
ROS, but instead leads to a differentially altered signaling state. To
determine whether the phosphorylation changes were regulated
enzymatically or by protein expression levels, we immunoblotted
for a subset of proteins most strongly affected by the treatment.
While changes in protein expression explain differences for CEAM1/
2 and GSTM phosphorylation (McLellan et al, 1992), INSR and
F16P1 expression levels display opposite trends as compared to
their pTyr patterns (Fig 6E), indicating that these nodes are likely
controlled by altered activity of kinases and/or phosphatases.
Finally, to establish the phenotypic effect of BHA supplementation
to HFD, we quantified starved blood glucose and tolerance to insulin
and glucose. For all parameters, animals fed BHA in the diet scored
significantly better than the HFD control group, suggesting that BHA
supplementation offsets the negative phenotypic consequences of
HFD (Figs 6F and G, and EV6B and C).
Discussion
The development of selective insulin resistance associated with high
calorie diets and obesity has been well documented (Biddinger &
Kahn, 2006; Brown & Goldstein, 2008; Titchenell et al, 2015, 2016),
but molecular features underpinning this process have been under-
explored. Recently, “omics”-type data sets were generated (Sabido´
et al, 2013; Soltis et al, 2017; Krahmer et al, 2018; Li et al, 2018)
using in vitro and in vivo models of fatty acid- and DIO-induced
insulin resistance that enable a much more comprehensive under-
standing of the complexity of this process by integrating genomics-,
metabolomics-, and proteomics-type information. Tyrosine phos-
phorylation and associated signaling cascades are an important
layer of regulation of cell behavior and phenotypic changes. With
the exception of two recent global phosphorylation studies (Krah-
mer et al, 2018; Li et al, 2018), signaling modifications associated
with excess lipid accumulation (e.g., triglycerides, FFAs, ceramides)
have so far been focused on individual signal transduction nodes
that have been found to play important roles in insulin resistance-
associated inflammation, lipotoxicity, and metabolic reprogramming
(Aguirre et al, 2000; O¨zcan et al, 2004; Fediuc et al, 2006; Han et al,
2013; Vernia et al, 2014, 2016). However, a systems-wide view of
the impact of calorie overload on tyrosine signaling networks in
insulin-response tissues has been missing.
In this study, we chose well-established in vitro and in vivo
models of diet- and fatty acid-induced insulin resistance to
◀ Figure 4. HFD alters response to insulin on proteins involved in glucose homeostasis and amino acid catabolism.A Schematic workflow of effects of HFD6 and HFD16 on insulin response (data set 1). Male mice were subjected to the same diet regiment as described in Figs 2A
and EV2A, and treated with insulin (10 U/kg) for 15, 30, or 60 min after overnight fasting (n = 2–4). Hepatic phosphotyrosine peptide abundances were assessed
relative to the same normalization sample as described in Fig 2A.
B Immunoblot analysis of pAkt-S473 in livers from insulin-treated mice fed a NC diet or HFD for 6 or 16 weeks. pAkt levels were normalized to total Akt and
expressed as normalized ratios (mean  SEM; n = 3–4; *P-value < 0.05; **P-value < 0.01; ***P-value < 0.005; # P-value < 5e-05 using unpaired t-test, two-sided).
C, D Insulin response of selected pTyr peptides from INSR/IGF1R and IRS1 and 2. Average peptide abundances are reported relative to the normalization sample (log2).
Significance between unstimulated and stimulated peptide levels for each diet was assessed as described in Fig 2A (n ≥ 2 animals; *P-value < 0.05;
**P-value < 0.01; ***P-value < 0.001 as determined by moderated and standard t-test, and rank products).
E Diagram of metabolic pathways with proteins whose tyrosine phosphorylation is changed significantly by diet, and phosphotyrosine levels relative to the
normalization sample after treating animals with insulin for indicated time points. Tyrosine position in mouse protein sequence is indicated by number above
quantification square.
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interrogate tyrosine phosphorylation changes in an unbiased
manner using multiplexed nanoflow LC-MS/MS. We used a cell-
based model of H4IIE rat hepatoma cells treated with saturated and
monounsaturated fatty acids to identify signaling changes as a direct
hepatic response to FFAs. This cell line is an established model that
reproduces physiologically relevant insulin responses as well as
lipid-associated insulin resistance phenotypes, including expression
changes underlying deregulated glucose metabolism and lipotoxicity
(Yang et al, 2005; Wei et al, 2007). Consistent with features associ-
ated with insulin resistance in vivo, PA but not OA attenuated
signaling through Akt as measured by pAkt-S473, increased mRNA
levels of the gluconeogenic enzyme glucose-6-phosphatase, and led
to elevated ROS levels in vitro (Schmoll et al, 2000; Puigserver et al,
2003). Here we examined whether saturated FFA might cause more
widespread effects on cellular signaling networks that could account
for transcriptional changes and the insulin-resistant phenotype. To
A C
B
D E
Figure 5. The majority of HFD-responsive pTyr sites are regulated independently of hepatic INSR expression.
A Immunoblot of INSR in livers of male InsrLoxP/LoxP mice (control) and of mice with liver-specific INSR knockout (Alb-cre InsrLoxP/LoxP, LIRKO).
B Schematic representation of pTyr analysis in liver-specific INSR knockout samples (LIRKO). Male LIRKO and control mice were fed an 8-week standard chow before
switching to HFD for 16 weeks as described in Fig 2A. Phosphotyrosine analysis was done as described above.
C Volcano plot of average pTyr ratios (log2) of LIRKO (n = 3) and control mice (n = 3). Statistical significance was assessed using a combination of moderated and
standard t-test and Benjamini-Hochberg correction. Yellow background, upregulated in LIRKO; green background, downregulated in LIRKO.
D Heatmap of average ratios of pTyr peptides in HFD16 relative to NC (right panel) and their sum-normalized levels in LIRKO and control mice after 16 weeks of HFD
(left panel). Shown are sites that were significantly (corrected P-value ≤ 0.05) affected by INSR knockout in the liver. Tyrosine position in mouse sequence is indicated
after the gene name followed by a number corresponding to peptide form (e.g., methionine oxidation, missed cleavage).
E RNA levels of proteins whose pTyr levels were significantly changed in LIRKO livers relative to control. Cycle threshold (Ct) values of the gene of interest were
normalized with the Ct of the housekeeping gene using the delta-Ct method (mean  SEM; n = 3; **P-value < 0.01; ***P-value < 0.001; n.s., not significant using
unpaired t-test). Yellow background, upregulated pTyr peptides in LIRKO; green background, downregulated pTyr peptides in LIRKO.
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this end, we employed a two-step enrichment protocol to enrich for
tyrosine phosphorylated peptides, an important signal transduction
mode known for its low-level abundance as compared to serine or
threonine phosphorylation. This analysis revealed significant time-
and concentration-dependent increases of tyrosine phosphorylation
in cells treated with palmitate. Many of the proteins affected are
signaling molecules that are canonical downstream effector nodes
onto which different RTK-linked signaling cascades converge,
including insulin-dependent signaling. These data suggest that satu-
rated fatty acids can induce a complex rewiring of the hepatic tyro-
sine network that goes beyond the JNK-mediated stress response
reported so far, and seems to especially affect SFK-dependent activi-
ties. Our data show that the response to saturated fatty acids alters
SFK signaling output dramatically, leading to the tyrosine
A
D E F
G
B C
Figure 6. Targeting ROS and SFK activity reverses FFA-induced signaling changes in vitro and in vivo.
A Principal component analysis of pTyr levels relative to BSA in H4IIE cells after treatment with indicated inhibitors in the presence of 0.25 mmol/l OA or PA for 12 h.
OA—oleic acid, PA—palmitic acid, N5—NAC 5 mmol/l, B200—BHA 0.2 mmol/l, R10—10 nmol/l, D200—dasatinib 200 nmol/l, D1000—dasatinib 1,000 nmol/l,
VC—vehicle control.
B Expression levels of glucose-6-phosphatase (G6Pase) after incubating H4IIE cells with 0.1 mmol/l FFA or BSA for 12 h in the presence of increasing concentrations of
dasatinib or NAC. RNA levels are expressed as ratios of treatment relative to untreated BSA (mean  SEM; n ≥ 4). Significance was assessed between FFA only and
FFA + inhibitor/antioxidant (*P-value < 0.05 using unpaired t-test).
C Representative immunoblot of Akt phosphorylation (S473) after insulin stimulation in the presence of FFAs with or without increasing concentrations of BHA or NAC.
Cells were incubated with BSA or FFA media and inhibitors for 12 h and then stimulated with 100 nmol/l insulin for 5 min.
D Volcano plot of average pTyr ratios (log2) of male HFD16 mice with or without 1.5% BHA supplementation. Mice were kept on a HFD + BHA (n = 5) or HFD - BHA
(n = 5) for 16 weeks, and pTyr levels were analyzed as described above. Statistical significance was determined as described in Fig 5C. Purple indicates that these
sites are differentially regulated by HFD as shown in Fig 2D.
E Immunoblot of selected proteins with peptides that are significantly changed in HFD16 + BHA and quantification of corresponding immunoblot bands
(mean  SEM; n = 4–5; *P-value < 0.05; **P-value < 0.01; n.s., not significant using unpaired Student’s t-test, two-sided).
F Glucose tolerance test (GTT) of HFD-fed mice with or without BHA supplementation to the diet (n = 10 per condition; mean  SEM; *P-value < 1e-03 using unpaired
Student’s t-test, two-sided).
G Results of insulin tolerance test (ITT) of HFD-fed mice with or without BHA supplementation to the diet (n = 10 per condition; mean  SEM; *P-value < 1e-03 using
unpaired Student’s t-test, two-sided).
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phosphorylation-mediated activation of a large number of down-
stream effector proteins and to changes in phenotypic outcome, in
line with PA-induced changes of lipid raft clustering and SRC local-
ization (Holzer et al, 2011).
We profiled protein expression and tyrosine phosphorylation in
an in vivo model of diet-induced obesity in two independent studies
that had differences in experimental design, housing, diet, sex, and
genetic background. These studies were not perfectly matched in
order to assess the translatability of our conclusions, and to capture
the highly dynamic and adaptive nature of liver metabolism.
Expression profiling in livers of male mice (data set 1) showed
that cytochrome P450 proteins were downregulated in HFD relative
to NC. These data suggest that diet composition regulates the
hepatic ability to metabolize specific drugs effectively, which may
alter the response to therapy in affected patients. It should be noted
that the expression of different members of the P450 superfamily is
sex-dependent (Wiwi et al, 2004), which could thus have a consid-
erable influence on diet effects, including which members are
affected. Interestingly, we found that EGFR expression was differen-
tially regulated by diet in the two studies. In data set 1 where male
mice were used, HFD downregulated the expression of EGFR,
whereas the opposite effect on female mice was observed in data set
2. Despite other differences in the study designs, it is tempting to
speculate that the reported sex bias in the regulation of EGFR
expression (Scoccia et al, 1991; Rando & Wahli, 2011) may translate
to a differential response to caloric overload. These data warrant
further investigation given EGFR’s role in mediating growth-asso-
ciated cues.
Our data indicate that global rewiring of the hepatic tyrosine
phosphorylation network was largely reproducible despite the dif-
ferent experimental conditions used, and that changes in protein
expression contribute to only some of the signaling alterations. The
majority of reproducibly affected phosphotyrosine sites are found in
proteins that are involved in important metabolic processes as well
as cell motility and cytoskeletal functions. For most affected tyrosi-
nes in metabolic enzymes, functional characterization is still miss-
ing, but enzyme activity may be affected by phosphorylation either
through direct activity modification or through indirect effects on
protein stability or localization. Additionally, we identified sites in
RTKs and associated adaptor and downstream nodes, including
INSR (activation loop), IRS2, SFKs, and PI3K regulatory subunits,
whose phosphorylation was upregulated by HFD, in two separate
cohorts under different HFD conditions. While many of the sites
were similarly regulated by the diets, some sites displayed opposite
trends or were not identified across all samples, a feature common
to discovery mode mass spectrometry analysis. Additional studies
using targeted proteomics approaches may provide further insight
into the effects of diet on those proteins.
When livers of mice treated with insulin were analyzed, we
found that despite already elevated INSR phosphorylation in HFD
compared to NC, the hormone was still able to elicit a strong INSR
and IRS1 response in HFD mice, similar to that observed in livers of
NC animals. However, phosphorylation of metabolic enzymes
upregulated by diet failed to respond to insulin altogether in HFD-
fed animals, suggesting a diet-induced rewiring of metabolic activi-
ties. Interestingly, in cases where these sites were affected by insulin
in NC livers, the response to ligand was much more subdued
compared to the effects of diet, indicative of a tightly regulated
signaling cascade that is compromised by HFD-induced signaling.
Furthermore, we found that the diet-induced increase in tyrosine
phosphorylation on the majority of proteins is independent of
hepatic INSR expression and therefore cannot be attributed to
hyperinsulinemia alone. Taken together, these data strongly suggest
that the consumption of a HFD rewires and increases tyrosine-
dependent signaling in a manner that is different from receptor-
mediated signaling. This result supports the idea that the impact of
HFD is much broader and not limited to impairing insulin’s canoni-
cal regulatory functions in glucose metabolism.
Data from in vitro and in vivo models showed a remarkably
widespread effect of lipid overload on the hepatic tyrosine signaling
network, encompassing a variety of protein families, signaling path-
ways, and biological functions. We argue that these unselective
effects could be due to activation of different kinase families such as
SFKs or deactivation of tyrosine kinase phosphatases through
increased ROS levels. Both processes have been associated with
diabetes and insulin resistance in vivo (Houstis et al, 2006; Bastie
et al, 2007; Yamada et al, 2010; Holzer et al, 2011; Gurzov et al,
2014). These results prompted us to explore the potential of SFK
inhibitors (SFKi) and antioxidants as easily accessible strategies to
mitigate the effects of insulin resistance. Inhibition of SFKs by dasa-
tinib led to a marked reduction of tyrosine phosphorylation sites
that were upregulated by palmitate in our cell-based assay. Some of
the dasatinib-sensitive sites were also significantly upregulated in
the in vivo data sets, suggesting SFK inhibition may be a valid strat-
egy to counter diet-induced signaling changes associated with dereg-
ulated glucose homeostasis and other metabolic processes. These
observations are in agreement with findings that treatment with
SFKi (Holzer et al, 2011) or ablation of SFK gene expression causes
improved glycemia in mice fed a HFD (Bastie et al, 2007).
The antioxidants NAC and BHA were able to reduce PA-induced
phosphorylation on a subset of proteins in vitro, suggesting that
ROS levels are directly associated with pTyr-signaling changes, most
likely through inhibition of PTPs or activation of protein kinases, or
potentially both. Despite overlapping sites, both antioxidants had
effects distinct from each other. Previous studies have shown that
NAC can exert its action by directly reacting with another molecule
via a reductive thiol-disulfide exchange reaction. It thereby modu-
lates the redox state of target proteins, potentially affecting activity,
localization, or stability. The in vitro antioxidant properties of BHA
are mostly derived from its scavenging activity of free radicals,
which could explain differences in the phosphorylation response to
NAC and BHA. Among the common sites, we found that phosphory-
lation on some SFK substrates was reduced when PA was combined
with NAC or BHA. However, we failed to detect significant effects
on the SFK autophosphorylation site. This could be due to the
inability to associate the non-unique SFK autophosphorylation
peptide with a single SFK protein by mass spectrometry. It could
also indicate that SFK substrates, but not SFK activity, are regulated
by ROS-linked effects, suggesting a role for ROS-mediated alter-
ations in phosphatase activity.
Supplementing HFD with BHA in vivo, we found a substantial
downregulation of diet-induced tyrosine phosphorylation, affecting
INSR as well as known and potential novel downstream effector
proteins. It is unclear whether these effects are exclusively due to
antioxidant activity leading to activation of PTPs, but the data indi-
cate that a relatively untargeted method that leads to decreased ROS
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burden can globally reverse elevated tyrosine phosphorylation in a
model of insulin resistance. Because BHA was added to the diet,
whole-body effects that may or may not be due to alterations in
hepatic signaling can be expected. Indeed, we found that BHA
supplementation led to significantly improved glucose homeostasis
and insulin tolerance.
Unfortunately, BHA did not simply revert the effects of HFD,
but instead led to a novel signaling state, as BHA increased diet-
induced tyrosine phosphorylation even further for some proteins,
including FAK1 (Y614) and F16P1 (Y216, 265). While FAK1-
pY614 is implicated in SRC binding (Owen et al, 1999), F16P1
phosphorylation sites have not been annotated functionally yet.
Together with increased PTPRE-pY695 (Berman-Golan & Elson,
2007), increased FAK-pY614 can lead to increased SRC activity,
yet our data indicate a decrease in SFK substrate phosphorylation
on BHA supplementation. Future studies are needed to address
this observation using alternative antioxidants such as Resveratrol.
Taken together, BHA leads to the desired effect of mitigating diet-
induced metabolic deregulation and reverses diet-rewired hepatic
tyrosine network but also induces effects of unknown
consequences on a post-translational and potentially transcrip-
tional level.
In summary, we were able to show that lipid and fatty acid over-
load can lead to considerable rewiring of the tyrosine signal trans-
duction networks in vitro and in vivo. These effects happen
concurrently to the development of insulin resistance, and it could
be speculated that changes to the signal transduction pathways in
the liver are important drivers for hepatic dysfunction. In line with
previous studies on tyrosine phosphatases (Gurzov et al, 2014) and
the role of SFKs in fatty acid metabolism and insulin biology (Bastie
et al, 2007; Holzer et al, 2011), we were able to show that targeting
increased SFK activities or reducing ROS levels and their deactivat-
ing effect on PTPs have a significant impact on diet-rewired signal-
ing networks and phenotypic output. Future studies should be
aimed at identifying how these changes influence glucose homeosta-
sis and the activation state of affected metabolic enzymes. Taken
together, these data significantly extend the insight into molecular
underpinnings of the development of diet-induced diabetes and
potentially other insulin resistance-associated diseases, and provide
a framework for new therapeutic hypotheses.
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or Source Identifier or Catalog Number
Experimental models
C57BL/6J (Mus musculus) Jackson Lab Stock number 000664
B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J (Mus musculus) Jackson Lab, Postic et al (1999) Stock number 003574
B6.129S4(FVB)-Insrtm1Khn/J (Mus musculus) Jackson Lab, Brüning et al, 1998 Stock number 006955
B6.129S4-Gt(ROSA)26Sortm1Sor/J (Mus musculus) Jackson Lab Stock number 003474
B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (Mus musculus) Jackson Lab Stock number 008875
H4IIE (Rattus norvegicus) Novo Nordisk
Antibodies
pAkt-S473 Cell Signaling Technology 4060
Total Akt Cell Signaling Technology 2920
AL1A1 Cell Signaling Technology 12035
CEAM1/2 Cell Signaling Technology 14771
INSR Cell Signaling Technology 3020
pINSR Cell Signaling Technology 3024
EGFR Cell Signaling Technology 4267
pERK Cell Signaling Technology 9101
F16P1 Cell Signaling Technology 59172
GSTM1/2/4/5 Abcam 178684
PYC Abcam 128952
GAPDH Santa Cruz 20357
b-actin Cell Signaling Technology 4967
anti-rabbit IRDye 680 LI-COR Biosciences 926–68023
anti-rabbit IRDye 800 LI-COR Biosciences 926–32211
anti-mouse IRDye 680 LI-COR Biosciences 926–68022
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source Identifier or Catalog Number
anti-mouseI RDye 800 LI-COR Biosciences 926–32210
Oligonucleotides and sequence-based reagents
Mouse/rat Hprt forward primer This study CTCATGGACTGATTATGGACAGGAC
Mouse/rat Hprt reverse primer This study GCAGGTCAGCAAAGAACTTATAGCC
Rat Rplp0 forward primer This study GGCGACCTGGAAGTCCAACT
Rat Rplp0 reverse primer This study GGATCTGCTGCATCTGCTTG
Rat G6pc forward primer This study AGCTCCGTGCCTCTGATAAA
Rat G6pc reverse primer This study CCCAGTATCCCAACCACAAG
Mouse Egfr forward primer This study GAAGCCTATGTGATGGCTAGTG
Mouse Egfr reverse primer This study AGGGCATGAGCTGTGTAATG
Mouse Glud1 forward primer This study ATCGGGTGCATCTGAGAAAG
Mouse Glud1 reverse primer This study CAGGTCCAATCCCAGGTTATAC
Mouse Aldh1a1 forward primer This study GAGAGTGGGAAGAAAGAAGGAG
Mouse Aldh1a1 reverse primer This study CTCATCAGTCACGTTGGAGAA
Mouse Dbi forward primer This study GATACATTAGGGCCAGCGTTA
Mouse Dbi reverse primer This study CCCAGGCACAGAGTAACAAA
Mouse Pcx forward primer This study CTCCGACGTGTATGAGAATGAG
Mouse Pcx reverse primer This study CATCTGGTTAGCCTCCACATAG
Mouse Stat3 forward primer This study CCTTCTGCTTCGAGACAGTTAC
Mouse Stat3 reverse primer This study AGCCTTGCCTTCCTAAATACC
Mouse Fbp1 forward primer This study CTACGCTACCTGTGTTCTTGTG
Mouse Fbp1 reverse primer This study AGGCAGTCAATGTTGGATGAG
Mouse Irs2 forward primer This study CTCGGACAGCTTCTTCTTCATC
Mouse Irs2 reverse primer This study GGATGGTCTCATGGATGTTCTG
Chemicals, enzymes and other reagents
Sequencing grade Trypsin Promega V5111
Trypsin-EDTA (0.05%) Thermo Fisher Scientific 25300096
MEM Thermo Fisher Scientific 31095029
Non-essential amino acids Thermo Fisher Scientific 11140050
Mycoplasma detection kit Lonza LT07-218
Fetal bovine serum Thermo Fisher Scientific 16000044
5 lm C18, ODS-AQ, 12 nm YMC AQ12S05
10 lm C18, ODS-A, 12 nm YMC AA12S11
Poros 20 MC metal chelate affinity resin Applied Biosystems 1542906
Dasatinib Selleckchem S1021, lot 8
Palmitic Acid Sigma Aldrich P5585
Oleic Acid Sigma Aldrich O1383
NaOH 1N Sigma Aldrich S2770
Iron Chloride Sigma Aldrich 451649
BCA assay kit Thermo Fisher Scientific 23225
NuPAGETM 4–12% Bis-Tris Midi Protein Gels Thermo Fisher Scientific WG1402BX10
Nitrocellulose membrane BioRad 1620112
ROS Sigma Aldrich MAK143
Blotting paper VWR 10427805
Blocking buffer LI-COR Biosciences 927–40000
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source Identifier or Catalog Number
Prolab Isopro RMH 3000 Purina Lab Diet 0006973
Mouse high-fat diet 1 Bioserv S3282
Mouse high-fat diet 2 OpenSource Diets D12492
Butylated hydroxyanisole Sigma Aldrich B1253
Insulin Novilin R Novo Nordisk U-100
Glucose J.T. Baker 1916-01
TRIzol Thermo Fisher Scientific 15596018
High Capacity cDNA Reverse Transcription kit Thermo Fisher Scientific 4368814
RNA isolation kit Zymo Research R2050
iQ SYBR Green Supermix BioRad 1708880
Urea Sigma Aldrich U5128
PhosStop Sigma Aldrich 4906845001
Protease inh cocktail Roche 4693116001
Dithiothreitol Sigma Aldrich 43819
Iodoacetamide Sigma Aldrich I1149
Triethylammonium bicarbonate buffer Sigma Aldrich T7408
SepPak Plus Waters WAT020515
TMT reagent Thermo Fisher Scientific 90406/90068
PT66 Sigma Aldrich P3300
Anti-Phosphotyrosine Antibody, clone 4G10 Merck Millipore 05-321
Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cell Signaling Technology 9411
Protein G Plus-Agarose Suspension Merck Millipore IP04
Sodium phosphate monobasic Sigma Aldrich S3139
Trizma base Sigma Aldrich T1503
Acetonitrile Sigma Aldrich 34998
Acetic acid Sigma Aldrich 338826
Software
R 3.5.1 https://www.r-project.org/
Graph Pad Prism 6.07 https://www.graphpad.com/
IncuCyte version 2016B software https://www.essenbioscience.com/en/products/sof
tware/
Mascot version 2.4 http://www.matrixscience.com/
Proteome Discoverer version 1.4.1.14 Thermo Fisher Scientific
CAMV version 1.2 https://github.com/white-lab/CAMV
Other
Infinite 200 Pro microplate reader Tecan
IncuCyte ZOOM live cell imager Essen Bioscience
Cell Culture microplate, 96-well, black, cearbottom Greiner Bio-One 655090
speed vac Thermo Fisher Scientific
syringe pump Harvard Apparatus
tissue homogenizer VWR
C1000 Touch Thermo Cycler BioRad CFX384
100 lm capillaries Molex, LLC - Polymicro Technologies TSP100375
50 lm capillaries Molex, LLC - Polymicro Technologies TSP050375
200 lm capillaries Molex, LLC - Polymicro Technologies TSP200350
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source Identifier or Catalog Number
FC203B fraction collector Gilson 171011
Zorbax 300Extend-C18 5 lm 4.6 × 250 mm Agilent 770995-902
1200 Infinity LC systems Agilent
Orbitrap Q-Exactive Plus/Q Exactive HF-x Thermo Fisher Scientific
Easy-nLC 1000 Thermo Fisher Scientific
PicoFrit capillary column 50 lm ID × 15 cm New Objective PF360-50-##-N-5
Methods and Protocols
Materials
All chemicals were obtained from Sigma unless otherwise stated.
5 lm (ODS-AQ, 12 nm, AQ12S05) and 10 lm (ODS-A, 12 nm,
AA12S11) reversed-phase HPLC C18 material were purchased from
YMC. Poros 20 MC metal chelate affinity resin was purchased from
Applied Biosystems. Dasatinib was purchased from Selleckchem.
Cell culture
H4IIE cells were maintained in low glucose Minimum Essential
Medium containing 10% FBS, 1% non-essential amino acids, and 1%
L-glutamine. Cells were tested to be mycoplasma free. For short time-
point treatments (< 12 h), cells were starved in medium alone for
12 h before the addition of FFA/BSA medium. Fatty acid stock solu-
tions were prepared by coupling FFAs with bovine serum albumin
(BSA). First, palmitate was dissolved in 0.01 N NaOH to final concen-
trations of 2–10 mmol/l while heating at 70°C for 3–5 h. Oleate was
dissolved in 0.01 N NaOH and heated at 37°C. Fatty acid solution was
added to equal parts of 37°C warm 10% BSA in PBS and heated at
37°C for 15 min. Inhibitor and antioxidant treatment were performed
for 12 h in the presence of 0.25 mmol/l FFA before cell lysis. Cells
were approximately 50% confluent before starving and treatment.
Animals
Data set 1: We obtained C57BL/6J mice (stock number 000664), Alb-
cre mice (stock number 003574; Postic et al, 1999), and InsrLoxP/
LoxP mice (stock number 006955; Bru¨ning et al, 1998) from the
Jackson Laboratory. Studies were performed using male mice on the
C57BL/6J background. All mice were housed in a specific pathogen-
free facility accredited by the American Association for Laboratory
Animal Care. We fed the mice either (i) a normal chow diet (NC,
Prolab Isopro RMH 3000, Purina) for 24 weeks, or (ii) standard NC
followed by 6 or 16 weeks of high-fat diet (HFD, S3282, Bioserv)
until an age of 24 weeks to obtain the same age end-point. For exper-
iments with BHA (2(3)-tert-butyl-4 hydroxyanisole), the high-fat diet
contained 1.5% BHA. We measured fat and lean mass noninvasively
using 1H-MRS (Echo Medical Systems). All experiments were carried
out in accordance with guidelines for the use of laboratory animals
and were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Massachusetts Medical
School. Mice were fasted overnight (18 h) and treated by intraperi-
toneal injection with insulin (Novilin R, Norvo Nordisk) for the indi-
cated time points prior to liver resection.
Mice used in data set 2 were female C57BL/6J mice [Rosa26-LSL-
LacZ (stock number: 003474) × Lgr5-eGFP-IRES-CreERT2 (stock
number: 008875)]. Mice were housed in the animal facility at the
Koch Institute for Integrative Cancer Research at MIT, and studies
pertaining to data set 2 were approved by the MIT Institutional
Animal Care and Use Committee. Mice were fed a normal chow
(NC) for at least 12 weeks (Prolab RMH 3000, LabDiet) followed by
12 or 30 weeks of HFD (D12492, OpenSource Diets), with age-
matched control mice staying on normal chow fed ad libitum. The
mice were fed ad libitum prior to liver resection.
GTT, ITT, and blood glucose measurements
Glucose tolerance tests (GTT) were performed by intraperitoneal
injection of fasted (18 h) mice with glucose (1 g/kg). Insulin toler-
ance tests (ITT) were performed by intraperitoneal injection of fed
mice with insulin (0.75 U/kg). Blood glucose was measured at the
indicated times with an Ascensia Breeze 2 glucometer (Bayer).
Liver resection and pulverization
Mice were euthanized at the indicated time points after an overnight
fast. Livers were frozen prior to removal using clamps cooled in
liquid nitrogen. The frozen livers were then pulverized into a
powder using a CryoPREP impactor (Covaris) or frozen as whole
organs.
ROS measurement
Cells were cultured as described above and plated at 1,000–3,500
cells per well on black 96-well tissue plates in 4–8 replicates. They
were grown overnight to a confluency of 85–95% for short time
points, or to 50% confluency for time points exceeding 12 h, after
which they were treated with BSA-conjugated FFA or BSA alone for
6–48 h. For ROS measurements, media was removed and replaced
with fresh media without BSA and FFA, mixed with the same
volume of assay buffer from a fluorometric intracellular ROS kit
(MAK145, Sigma-Aldrich), and a cell-permeable ROS detection
reagent, which provides readout especially for superoxide and
hydroxyl radicals. Cells were imaged every 15 min using an Incu-
Cyte ZOOM live cell imager (Essen Biosciences) setup with a 4×
objective and dual color filter, and fluorescence was measured using
IncuCyte version 2016B software over 3–4 h in culture. The
measurement at which maximal fluorescence was reached, typically
1 h of incubation with ROS detection reagent, was used to compute
average relative ratios of total green fluorescence intensity of FFA
relative to BSA control wells.
Isolation of RNA and protein
RNA of H4IIE cultures was isolated from an ~80% confluent well of
a 6-well plate with at least three biological replicates per condition.
Cells were grown for indicated times, washed twice with ice-cold
PBS, and lysed in TRIzol reagent (Thermo Fisher Scientific).
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Pulverized mouse livers were homogenized in TRIzol. These
samples were mixed thoroughly with an equal volume of nuclease-
free ethanol, and total RNA was isolated using Direct-zol RNA mini-
prep kit (Zymo Research) following the manufacturer’s protocol,
including on-column Dnase I digestion. Concentration and quality
of RNA were determined using a NanoDrop One spectrophotometer
(Thermo Fisher Scientific). Proteins were extracted from cells using
a modified RIPA buffer (50 mmol/l HEPES, 150 mmol/l NaCl, 1%
NP-40, 0.5% SDS) supplemented with protease inhibitors (HALT,
Thermo Fisher Scientific). Protein concentration was measured by
bicinchoninic acid (BCA) assay (Thermo Fisher Scientific).
Quantitative real-time PCR
Total RNA (1 lg) was transcribed using the rMoMuLV-based
reverse transcriptase (High Capacity cDNA Reverse Transcription
kit, Applied Biosystems). SYBR-green (iQ SYBR Green Supermix,
Bio-Rad) was used for the quantitative RT–PCR with the following
amplification cycles: cycle of 95°C for 30 s, 40 cycles of 95°C for
15 s, and 60°C for 30 s, followed by 65°C for 5 s and a subsequent
melting curve up to 95°C in increments of 0.5°C using the C1000
Touch Thermo Cycler (CFX384, Bio-Rad) operated with CFX
Manager version 3.1 (Bio-Rad). Selected amplification products
were further analyzed by PAGE. Up to two primers (Reagents Table)
were designed for each gene of interest, and each biological repli-
cate (three or more) was amplified in triplicate. The Hprt gene was
used as normalization control for mouse livers and Hprt and Rplp0
for H4IIE cells. Target expression in fatty acid-treated samples was
calculated as DDCT between internal control-normalized BSA
samples and internal control-normalized FFA. Target expression of
genes in LIRKO/Insrf/f samples was calculated as DCT between the
gene of interest and internal loading control.
Immunoblot analysis
Immunoblot analysis of proteins from tissue samples was done
using urea homogenate as described below for MS analysis. Protein
lysates from cell lines were prepared using a modified RIPA buffer
as described above. Proteins were separated on a precast gradient
(4–12%) Bis-Tris gel and transferred to a nitrocellulose membrane.
The membrane was blocked with Odyssey blocking buffer for 1 h at
room temperature and incubated with primary antibodies against
pAkt-S473 (CST4060), total Akt (CST2920), AL1A1 (CST12035),
CEAM1/2 (CST14771), INSR(CST3020), pINSR (CST3024), EGFR
(CST4267), pERK (CST9101), F16P1 (CST59172), fibronectin
(Abcam ab2413), GSTM1/2/4/5 (Abcam ab178684), and PYC
(Abcam 128952) overnight at 4°C. GAPDH (sc-20357) or b-actin
(CST4967) was used as loading control. The next day, the blot was
incubated with secondary antibodies coupled to IRDye 680 or 800
(LI-COR) for 1 h at room temperature, and immunocomplexes were
visualized using an Odyssey scanner CLx (LI-COR) and analyzed
with Image Studio version 3.1 and 5.0.
Sample preparation for MS
• Lyse-frozen mouse livers in 8 mol/l urea supplemented with
1 mmol/l sodium orthovanadate (Na3VO4), 0.1% Nonidet P-40,
protease inhibitor cocktail (1 tablet/10 ml), and PhosStop using a
7 mm homogenizer unit with two short pulses at 1565–3522 × g.
• Wash cells with PBS and lyse in 200 ll 8 mol/l urea per 10-cm dish.
o Measure protein concentration by BCA assay using the manu-
facturer’s instruction.
o Reduce disulfide bonds with 10 mmol/l dithiothreitol (DTT) in
100 mmol/l ammonium acetate for 45 min at 56°C and
o Alkylate sulfhydryl groups with 55 mmol/l iodoacetamide
(IAA) for 45 min at room temperature in the dark.
o Dilute lysates 8-fold with 100 mmol/l ammonium acetate, pH
8.9 and digest proteins with trypsin (sequencing-grade,
Promega) overnight at room temperature at a protein:trypsin
ratio of 1:50 (w/w).
o Stop the digestion by adding formic acid to 2% and desalt
peptides using SepPak Plus cartridges and a syringe pump
operated at 2 ml/min for washing and 1 ml/min for loading
and eluting (solvent A: 0.1% formic acid, solvent B: 0.1%
formic acid/60% ACN)
o Reduce peptide volume in a speedvac concentrator, before snap
freezing four hundred microgram per sample in liquid nitrogen
for lyophilization. Store lyophilized peptides at80°C.
o Label peptides were labeled with TMT6/10-plex reagents in
70% ethanol/115 mmol/l triethylammonium bicarbonate
(TEAB), pH 8.5 for 1 h at room temperature.
o Pool samples after 1 h of labeling, bring to dryness in a speed-
vac, and store at 80°C until analysis.
• A normalization control corresponding to one animal on normal
chow diet treated with insulin for 30 min was included in all
multiplexed mass spectrometry analyses. This enabled compar-
ison of the effects of high-fat diet on basal and insulin-responsive
phosphotyrosine sites (Dataset EV2) across multiple MS runs. The
effects of liver-specific insulin receptor knockout (LIRKO) were
evaluated by analyzing three animals per condition in a TMT6-
plex setup. Effects of butylated hydroxyanisole (BHA, Sigma-
Aldrich) on phosphotyrosine levels were evaluated in a TMT10-
plex setup with five animals per condition.
Phosphopeptide enrichment
• Conjugate protein G agarose beads with 12 lg 4G10, 6 lg PY-100,
and 12 lg PT-66 in 300 ll IP buffer (100 mmol/l Tris–HCl, 1%
Nonidet P-40 at pH 7.4 for approximately 3 h at 4°C).
• Resuspend dried labeled peptides in 400 ll IP buffer, add to anti-
body beads, and incubate overnight.
• Collect beads and save supernatant (non-bound fraction) for a
limited LC-MS/MS analysis of peptide levels probing peptides from
the most abundant proteins. These data were used for adjustment of
between-channel loading variations as described below.
• Wash beads once with IP buffer and three times with rinse buffer
(100 mmol/l Tris–HCl at pH 7.4).
• Elute peptides with 100 mmol/l glycine, pH 2.5, 12.5% acetoni-
trile for 30 min at room temperature.
• In the meantime, load a capillary column (200 lm ID × 10 cm)
in-house packed with metal chelate affinity resin with 100 mmol/l
Iron(III) chloride for 30 min at a flow rate of 10 ll/min and wash
with 0.1% acetic acid.
• Load eluted peptides from the phosphotyrosine IP at a flow rate of
1–2 ll/min on a pressure injection cell.
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• Wash the column with 100 mmol/l NaCl, 25% acetonitrile, 1%
acetic acid for 15 min, and 0.1% acetic acid for 10 min.
• Elute phosphopeptides onto an acidified trapping column (100 lm
ID × 10 cm, 10 lm C18) connected in line with the Fe3+-IMAC
column using 250 mmol/l NaH2PO4, pH 8.0 at a flow rate of 1–
2 ll/min.
• Rinse the column with 0.2 mol/l acetic acid (Solvent A) for
15 min before LC-MS/MS analysis as described below.
For a comprehensive quantitative global proteomics analysis, one-
fourth of supernatants from two phosphotyrosine IPs containing
labeled peptides from three animals on normal chow and three
animals on 16-week high-fat diet (corresponding to approx. 1 mg of
protein) were fractionated using an Agilent Zorbax 300Extend-C18
5 lm 4.6 × 250 mm column on an Agilent 1200 operating at 1 ml/
min. Buffer A consisted of 10 mmol/l TEAB, pH 8.0 and buffer B
consisted of 10 mmol/l TEAB with 99% acetonitrile, pH 8.0. Fractions
were collected using a Gilson FC203B fraction collector at 1-min inter-
vals. Samples were loaded onto the column at 1 ml/min and eluted
with the following fractionation gradient: 1% B to 5% B in 10 min, 5–
35% B in 60 min, ramped to 70% B in 15 min, held for 5 min before
equilibrating back to 1% B. Fractions 10–90 were used for concatena-
tion to 20 fractions. After concatenation, solvent volume was reduced
in a speedvac before flash freezing and lyophilization.
Reversed-phase nano-LC-MS/MS
LC-MS/MS of phosphotyrosine eluates was carried out as follows.
Peptide separation was carried out on an Agilent 1260 (Agilent Tech-
nologies) coupled to an Orbitrap Q-Exactive Plus or Q Exactive HF-x
(Thermo Scientific). The washed trapping column containing phospho-
tyrosine peptides from the Fe3+-IMAC elution was connected in series
with an in-house packed analytical capillary column (50 lm
ID × 12 cm, 5 lm C18) with an integrated electrospray tip (1–2 lm ori-
fice). Peptides were eluted with 70% acetonitrile in 0.2 mol/l acetic
acid (Solvent B) in following gradients: 0–13% solvent B in 10 min, 13–
42% in 95 min, 42–60% in 10 min, 60–100% in 5 min, and 100% for
8 min, before equilibrating back to Solvent A. The flow was split to
approximately 20 nl/min. The mass spectrometer was operated in posi-
tive ion mode with a spray voltage of 2 kV and heated capillary temper-
ature of 250°C. MS data were obtained in data-dependent acquisition
mode. Full scans (MS1) were acquired in the m/z range of 350–2,000 at
a resolution of 70,000 (m/z 200, QEPlus) or 60,000 (HF-X), with AGC
target 3E6 and a maximum injection time of 50 ms. The top 15 most
intense precursor ions were selected and isolated with an isolation
width of 0.4 m/z and dynamic exclusion set to 30 s. Selected ions were
HCD fragmented at normalized collision energy (NCE) 33% after accu-
mulating to target value 1E5 with a maximum injection time of 350 ms.
MS/MS acquisition was performed at a resolution of 35,000 (QEPlus) or
45,000 (HF-X). LC-MS/MS of fractionated samples was carried out on
an Orbitrap Q-Exactive Plus. Peptides were separated on a PicoFrit
capillary column (50 lm ID × 15 cm, Scientific Instrument Services)
with an integrated electrospray tip (10 lm orifice) in-house packed with
5-lm reversed-phase HPLC C18 material (ODS-AQ, 12 nm, AQ12S05,
YMC) on an Easy-nLC 1000 (Thermo). Peptides were eluted with 80%
acetonitrile in 0.1% formic acid (solvent B) in following gradients:
0–10% solvent B in 5 min, 10–30% in 100 min, 30–40% in 14 min,
40–60% in 5 min, 60–100% in 2 min, and 100% for 10 min, before
equilibrating back to 0.1% formic acid. All fractions were run back to
back to minimize effects from differences in instrument performance.
MS data were obtained in data-dependent acquisition mode with the
same parameters as described for phosphotyrosine samples.
Limited LC-MS/MS analysis of the most abundant peptides to
adjust for channel-to-channel loading variation was carried out on
an LTQ Orbitrap XL mass spectrometer. 100 ng of each IP super-
natant was loaded onto an acidified trapping column and analyzed
with gradients as follows: 0–13% solvent B in 6 min, 13–42% in
61 min, 42–60% in 7 min, 60–100% in 4 min, and 100% for 8 min,
before equilibrating back to Solvent A. Full scans (MS1) were
acquired in the m/z range of 350–2,000 at a resolution of 60,000
(m/z 200). The top 10 most intense precursor ions were selected
and isolated with an isolation width of 3 m/z and dynamic exclu-
sion set to 30 s. Selected ions were HCD fragmented at normalized
collision energy (NCE) 75% at a resolution of 60,000. Precursors
were re-isolated and CID-fragmented in the LTQ ion trap with
normalized collision energy 35%.
Peptide identification and quantification
Raw mass spectral data files were processed with Proteome Discov-
erer version 1.4.1.14 (DBversion: 79; Thermo Fisher Scientific) and
searched against the mouse (mouse livers) or rodent (H4IIE) Swis-
sProt database using Mascot version 2.4 (Matrix Science). TMT-
reporter quantification was extracted and isotope corrected in
Proteome Discoverer. MS/MS spectra were matched with an initial
mass tolerance of 10 ppm on precursor masses and 20 mmu for
fragment ions. Cysteine carbamidomethylation, TMT-labeled lysine,
and peptide N-termini were searched as fixed modifications.
Oxidized methionine and phosphorylation of serine, threonine, and
tyrosine were searched as variable modifications. Phosphorylation
site localization of tyrosine data was done manually using CAMV
version 1.2 on all peptide spectrum matches with mascot
score > 10. Peptide spectrum matches for global proteomics data
were filtered by mascot score (≥ 25) and precursor isolation interfer-
ence (< 31%), leading to an FDR of < 0.3%. Only proteins with at
least two unique peptides or three quantified peptide-to-spectrum
matches (psms) were considered for further analysis.
Data analysis
Data transformation
Phosphopeptide reporter ion areas were corrected for loading varia-
tions within each TMT run using the median of peptide ratios of
each channel obtained from limited global proteomics analysis of IP
supernatant run on the Orbitrap XL. Reporter ion areas for each
phosphopeptide variant were summed and represented as ratios
between each condition and the normalization sample or, in the
case of LIRKO and BHA analyses, as fold-change between the aver-
aged summed intensities of the two conditions. Global proteomics
analysis was done using summed up reporter ion intensities of all
unique peptides and generating the average of those intensities
across the at least two animals per condition.
Visualization and statistical analysis
Data plotting and unpaired Student’s t-test followed by Holm-Sidak
multiple comparisons test were performed for Western blot, qPCR,
and phenotypic data using GraphPad Prism version 6.07 for
Windows (GraphPad Software, www.graphpad.com). Unless other-
wise stated, proteomics data were visualized and analyzed using
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corresponding R (R Core Team, 2017; version 3.4.1) packages. Dif-
ferential regulation for phosphoproteomics data where the number
of replicates does not exceed n = 3 was determined using a combi-
nation of moderated t-test (limma, version 3.34.0; Ritchie et al,
2015), rank products (RankProd, version 3.4.0; Hong et al, 2006),
and standard t-test (Schwa¨mmle et al, 2013). Conditions with higher
numbers of replicates were analyzed with a combination of standard
and moderated t-test only. P-values were adjusted for multiple
correction using Benjamini-Hochberg as implemented in the stats
package (version 3.4.1). Significance of differences in average
(n ≥ 2 biological replicates) protein expression between HFD16 and
NC was assessed by unpaired, two-tailed Student’s t-test.
Clustering and PCA analysis
Unsupervised hierarchical clustering using Euclidean distance and
ward.D agglomeration of pTyr peptide ratios was performed using the
R packages ComplexHeatmap (version 1.17.1; Gu et al, 2016), pvclust
(2.0-0), RColorBrewer (1.1-2; Neuwirth, 2014), and ggplot2 (2.2.1;
Wickham, 2009). Peptides used in the clustering were identified in at
least two animals/biological replicates per condition, and phosphosite
annotation for each peptide was manually validated. PCA analysis
was done using the R packages pls (version 2.7-0) and factoextra (ver-
sion 1.0.5; Kassambara & Mundt, 2017; Mevik et al, 2018).
Protein function and pathway annotation
DAVID gene ontology analysis was performed using the R packages
clusterProfiler (version 3.6.0; Yu et al, 2012, 2015),
RDAVIDWebService (version 1.16.0, GO_BP; Fresno & Ferna´ndez,
2013), interrogating org.Mm.e.g.db (version 3.5.0), or org.Rn.e.g.db
(version 3.5.0) within the Bioconductor software project (Huber
et al, 2015). Proteins/genes from all peptides identified in the corre-
sponding samples were used as the background list. Benjamini-
Hochberg was used as the P-value adjustment method.
PSEA analysis
SFK substrates were extracted from PhosphoSite Plus (Hornbeck
et al, 2015). For each protein, maximal normalized fold-changes
relative to BSA per FFA condition were used to test enrichment of
these substrates in a ranked list with the R package fgsea (version
1.4.1; preprint: Sergushichev, 2016) using 10,000 permutations of
the dataset and BH adjustment of P-values to estimate the statistical
significance of the enrichment score.
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium (http://proteomecentral.proteomexc
hange.org) via the PRIDE partner repository (Vizcaı´no et al, 2013)
with the dataset identifiers PXD011458 (https://www.ebi.ac.uk/
pride/archive/projects/PXD011458) and PXD013815 (https://www.
ebi.ac.uk/pride/archive/projects/PXD013815).
Expanded View for this article is available online.
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